SecurityTXMD / TherapeuticsMD, Inc. (88338N107)
Institutional Owners146 (5 N-Q Owners)
Institutional Shares172,658,525 - 79.77% (ex. N-Q)
Common Shares Outstanding216,439,483 shares (as of 2017-12-31)
Institutional Value$ 1,025,695,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

TherapeuticsMD, Inc. (NASDAQ:TXMD) has 146 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 172,658,525 shares. Largest shareholders include Bank of New York Mellon Corp, FMR LLC / Fidelity, JP Morgan Chase & Co, Price T Rowe Associates Inc /md/, BlackRock Inc., Vanguard Group Inc, Franklin Resources Inc, Smith Robert J, State Street Corp, and Voya Investment Management LLC.

TherapeuticsMD, Inc. (NASDAQ:TXMD) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-14 13F-HR WOLVERINE TRADING, LLC Call 38,600 233
2018-02-02 13F-HR Redmond Asset Management, LLC 100,109 100,109 0.00 530 605 14.15
2018-02-14 13F-HR MORGENS WATERFALL VINTIADIS & CO INC 112,000 112,000 0.00 592 676 14.19
2018-02-12 13F-HR CITIGROUP INC Put 100 23,300 23,200.00 1 141 14,000.00
2018-02-14 13F-HR CAPSTONE INVESTMENT ADVISORS, LLC 100,000 100,800 0.80 529 608 14.93
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 691,633 819,043 18.42 3,659 4,948 35.23
2018-02-05 SC 13G/A FRANKLIN RESOURCES INC 11,256,377 10,992,409 -2.35
2018-04-18 13F-HR/A-1 FNY Managed Accounts LLC Call 5 0 -100.00 0 0
2018-02-15 13F-HR Lido Advisors, LLC 13,313 13,313 0.00 62 80 29.03
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 58 37 -36.21 11 10 -9.09
2018-02-02 13F-HR US BANCORP \DE\ 84,794 84,794 0.00 449 512 14.03
2018-01-24 13F-HR IFP Advisors, Inc 5,322 1,600 -69.94 28 10 -64.29
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 1,817 0 -100.00 10 0 -100.00
2018-02-02 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 40,500 40,500 0.00 214 245 14.49
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 18 671 3,627.78 1 59 5,800.00
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 419,719 456,982 8.88 2,220 2,760 24.32
2018-02-14 13F-HR Point72 Asset Management, L.P. 282,600 0 -100.00 1,495 0 -100.00
2018-02-14 13F-HR Perigon Wealth Management, LLC 100 100 0.00 1 1 0.00
2018-02-12 13F-HR Institute for Wealth Management, LLC. 13,180 79
2018-02-14 13F-HR ProShare Advisors LLC 10,729 141,193 1,215.99 57 853 1,396.49
2018-02-02 13F-HR HUNTINGTON NATIONAL BANK 6,000 6,000 0.00 32 36 12.50
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-13 13F-HR LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 48,917 0 -100.00 259 0 -100.00
2018-02-14 13F-HR Advisor Group, Inc. 4,499 4,335 -3.65 25 27 8.00
2018-02-02 13F-HR COLUMBUS CIRCLE INVESTORS 2,017,780 0 -100.00 10,674 0 -100.00
2018-02-14 13F-HR Voya Investment Management LLC 3,227,432 3,316,724 2.77 17,073 20,033 17.34
2018-02-14 13F-HR HRS Investment Holdings, LLC 42,336 0 -100.00 224 0 -100.00
2018-02-08 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 113,000 113,000 0.00 598 683 14.21
2018-02-14 13F-HR 1492 Capital Management LLC 390,702 387,529 -0.81 2,067 2,341 13.26
2017-10-30 13F-HR Riggs Asset Managment Co. Inc. 10,000 0 -100.00 53 0 -100.00
2018-02-02 13F-HR FIRST MIDWEST BANK TRUST DIVISION 27,800 27,800 0.00 147 168 14.29
2018-01-17 13F-HR Cutler Group LP Call 103,100 26,300 -74.49 83 12 -85.54
2018-02-14 13F-HR DEUTSCHE BANK AG\ 153,178 378,841 147.32 810 2,286 182.22
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 165,017 155,122 -6.00 873 937 7.33
2018-02-14 13F-HR Tekla Capital Management LLC 0 420,000 0 2,537
2017-11-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 200,000 0 -100.00 1,054 0 -100.00
2018-02-14 SC 13G/A PRICE T ROWE ASSOCIATES INC /MD/ 15,076,755 17,431,395 15.62
2018-02-14 13F-HR NORTHERN TRUST CORP 1,945,907 2,011,731 3.38 10,293 12,151 18.05
2018-02-14 13F-HR ZEKE CAPITAL ADVISORS, LLC 10,330 62
2018-02-14 13F-HR STATE STREET CORP 3,836,235 3,910,939 1.95 20,297 23,620 16.37
2018-02-16 13F-HR/A-1 Commonwealth Equity Services, Inc 13,449 0 -100.00 97 0 -100.00
2017-11-08 13F-HR NEXT Financial Group, Inc 0 0
2018-02-09 13F-HR Dynamic Technology Lab Private Ltd 11,600 0 -100.00 62 0 -100.00
2018-02-21 13F-HR Hanson McClain, Inc. 500 500 0.00 3 3 0.00
2018-02-05 13F-HR First Eagle Investment Management, LLC 1,568,092 9,471
2018-02-05 13F-HR STONERIDGE INVESTMENT PARTNERS LLC 145,692 145,692 0.00 771 880 14.14
2018-04-18 13F-HR Creative Planning 12,500 14,500 16.00 76 71 -6.58
2018-02-09 13F-HR Virtu Financial LLC 69,058 0 -100.00 365 0 -100.00
2018-02-02 13F-HR Claraphi Advisory Network, Llc 45,500 275
2018-02-07 13F-HR Swiss National Bank 289,800 289,800 0.00 1,533 1,750 14.16
2018-02-14 13F-HR Newtyn Management, LLC 1,800,000 1,250,000 -30.56 9,522 7,550 -20.71
2018-02-14 13F-HR Invesco Ltd. 37,295 37,537 0.65 197 227 15.23
2018-02-13 13F-HR Financial Gravity Companies, Inc. 147 1
2018-02-12 13F-HR Pacad Investment Ltd. 0 100 0 1
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC Call 3,000 0 -100.00 16 0 -100.00
2018-04-06 13F-HR Berson & Corrado Investment Advisors, LLC 54,125 76,185 40.76 327 371 13.46
2018-02-14 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 102,975 50,840 -50.63 545 307 -43.67
2017-11-22 N-Q Principal Exchange-traded Funds (see advisory)
2018-02-14 13F-HR MENTA CAPITAL LLC 0 111,166 0 671
2017-10-25 13F-HR HEARTLAND ADVISORS INC 300,000 0 -100.00 1,581 0 -100.00
2018-02-14 13F-HR ROYAL BANK OF CANADA 29,802 19,940 -33.09 158 121 -23.42
2018-02-14 13F-HR QCM Cayman, Ltd. 11,493 69
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC Put 1,000 600 -40.00 5 4 -20.00
2018-02-14 13F-HR HighTower Advisors, LLC 20,900 0 -100.00 111 0 -100.00
2018-01-17 13F-HR Cutler Group LP 2,428 14,864 512.19 12 89 641.67
2018-03-05 13F-HR MV Capital Management, Inc. 4,000 2,000 -50.00 21 12 -42.86
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 235,400 83,100 -64.70 1,245 502 -59.68
2018-02-13 13F-HR AMALGAMATED BANK 19,940 22,632 13.50 105 137 30.48
2018-02-02 13F-HR Aperio Group, LLC 34,227 33,603 -1.82 181 203 12.15
2018-02-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 32,485 49,931 53.70 172 302 75.58
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 249,825 261,142 4.53 1,322 1,577 19.29
2018-01-31 13F-HR GILDER GAGNON HOWE & CO LLC 2,470,766 246,969 -90.00 13,070 1,492 -88.58
2018-02-21 13F-HR/A-1 Xact Kapitalforvaltning AB 16,200 98
2018-02-12 13F-HR Atlantic Trust Group, LLC 12,100 73
2018-02-14 13F-HR Paloma Partners Management Co 0 17,290 0 105
2018-02-14 13F-HR MORGAN STANLEY 432,967 552,352 27.57 2,291 3,336 45.61
2018-02-07 13F-HR Candriam Luxembourg S.C.A. 530,000 200,000 -62.26 2,804 1,208 -56.92
2018-02-14 13F-HR MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 443,294 0 -100.00 2,345 0 -100.00
2018-04-14 SC 13D/A SMITH ROBERT J 12,959,108 9,938,708 -23.31
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 76,333 73,198 -4.11 404 441 9.16
2018-01-10 13F-HR SIMPLEX TRADING, LLC 8,585 0 -100.00 45 0 -100.00
2018-02-14 13F-HR Alyeska Investment Group, L.P. 531,610 231,023 -56.54 2,812 1,395 -50.39
2018-02-14 13F-HR Walleye Trading LLC 0 1,357 0 8
2018-02-02 13F-HR MEEDER ASSET MANAGEMENT INC 0 105 0 1
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 36,502 0 -100.00 193 0 -100.00
2018-02-14 13F-HR Natixis 19,434 0 -100.00 103 0 -100.00
2018-02-14 13F-HR UBS Group AG 31,512 31,463 -0.16 167 190 13.77
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 26,569 50,494 90.05 141 305 116.31
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 134,608 0 -100.00 712 0 -100.00
2018-02-15 13F-HR Metlife Investment Advisors, Llc 70,014 423
2018-04-10 13F-HR NISA INVESTMENT ADVISORS L.L.C. 0 825 0 4
2018-01-23 13F-HR Baystate Wealth Management LLC 4,000 26
2018-01-31 13F-HR Traynor Capital Management, Inc. 26,299 24,500 -6.84 134 147 9.70
2018-02-12 13F-HR OPPENHEIMER FUNDS INC 1,475,137 1,634,080 10.77 7,804 9,870 26.47
2018-04-20 13F-HR PRENTISS SMITH & CO INC 3,000 0 -100.00 18 0 -100.00
2018-02-12 13F-HR PRINCIPAL FINANCIAL GROUP INC 18,406 32,097 74.38 97 194 100.00
2018-02-14 13F-HR WOLVERINE TRADING, LLC 0 15,761 0 95
2018-02-14 13F-HR BlueCrest Capital Management Ltd 14,580 0 -100.00 77 0 -100.00
2018-01-22 13F-HR MANAGED ACCOUNT SERVICES INC 18,603 18,103 -2.69 98 109 11.22
2018-02-09 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 93,963 98,263 4.58 497,064 593,509 19.40
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 217,820 193,443 -11.19 1,153 1,169 1.39
2018-02-14 13F-HR HighTower Advisors, LLC Call 500 0 -100.00 0 0
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ Put 10,000 49
2018-02-13 13F-HR Legal & General Group Plc 61,683 59,564 -3.44 324 359 10.80
2018-02-07 SC 13G/A Bank of New York Mellon Corp 22,377,267 28,973,668 29.48
2018-02-14 13F-HR D. E. Shaw & Co., Inc. 709,290 1,497,665 111.15 3,752 9,046 141.10
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 12,961 12,961 0.00 77 78 1.30
2018-02-14 13F-HR Cubist Systematic Strategies, LLC 10,340 0 -100.00 55 0 -100.00
2018-01-31 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 3,824 7,336 91.84 20 44 120.00
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 121,883 128,099 5.10 644 774 20.19
2018-02-14 13F-HR AHL Partners LLP 11,708 0 -100.00 62 0 -100.00
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-02-01 13F-HR Nationwide Fund Advisors 87,403 0 -100.00 462 0 -100.00
2018-02-14 13F-HR RAYMOND JAMES & ASSOCIATES Call 78,000 34
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-09 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 15,700 15,700 0.00 80 95 18.75
2018-02-09 13F-HR RHUMBLINE ADVISERS 185,788 153,081 -17.60 983 925 -5.90
2018-02-14 13F-HR ALPINE WOODS CAPITAL INVESTORS, LLC 12,000 12,000 0.00 64 72 12.50
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 24,612 149
2018-02-16 13F-HR/A-1 J. Goldman & Co LP 814,500 587,394 -27.88 4,309 3,548 -17.66
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 74,200 75,700 2.02 393 457 16.28
2018-02-06 13F-HR ING GROEP NV 267,962 268,962 0.37 1,418 1,625 14.60
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 143,900 112,200 -22.03 761 678 -10.91
2018-02-14 13F-HR Rock Springs Capital Management LP 1,600,000 1,175,000 -26.56 8,464 7,097 -16.15
2017-11-14 13F-HR AQR CAPITAL MANAGEMENT LLC 26,903 0 -100.00 142 0 -100.00
2018-02-14 13F-HR RAYMOND JAMES & ASSOCIATES 389,563 520,561 33.63 2,061 3,144 52.55
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 198,535 161,933 -18.44 1,050 978 -6.86
2018-04-06 13F-HR Eqis Capital Management, Inc. 14,375 14,165 -1.46 87 69 -20.69
2018-02-14 13F-HR BARCLAYS PLC 3,617 110 -96.96 19 1 -94.74
2018-02-14 13F-HR NEXTHERA CAPITAL LP 528,351 3,191
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 409,882 393,864 -3.91 2,168 2,379 9.73
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 176,342 180,042 2.10 1,065 877 -17.65
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 28,900 175
2018-02-16 13F-HR/A-1 J. Goldman & Co LP Put 0 860,000 0 5,194
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 300 2,156 618.67 2 12 500.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 26,350 90,556 243.67 139 547 293.53
2018-02-01 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 74,954 74,954 0.00 397 453 14.11
2018-02-14 13F-HR BAMCO INC /NY/ 920,000 1,000,000 8.70 4,867 6,040 24.10
2018-02-14 13F-HR Walleye Trading LLC Call 11,300 68
2018-01-17 13F-HR Cutler Group LP Put 9,700 3,900 -59.79 21 4 -80.95
2018-02-12 13F-HR CITIGROUP INC 3,314 19,906 500.66 18 121 572.22
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 74,000 156,009 110.82 447 761 70.25
2018-02-14 13F-HR Mana Advisors Llc 17,256 104
2018-02-14 13F-HR ARDSLEY ADVISORY PARTNERS 25,000 1,050,000 4,100.00 132 6,342 4,704.55
2018-02-13 13F-HR GAGNON SECURITIES LLC 17,382 17,382 0.00 92 105 14.13
2018-02-02 13F-HR TD ASSET MANAGEMENT INC 296,470 326,702 10.20 1,568 1,973 25.83
2018-02-13 13F-HR PRUDENTIAL FINANCIAL INC 15,400 15,620 1.43 81 94 16.05
2017-11-16 13F-HR Cetera Investment Advisers 40,800 0 -100.00 214 0 -100.00
2018-01-29 13F-HR OUTFITTER ADVISORS, LTD. 51,532 51,532 0.00 273 311 13.92
2018-02-13 13F-HR Parallel Advisors, LLC 1,457 1,457 0.00 9 9 0.00
2018-03-05 13F-HR/A-1 NORGES BANK 1,431,705 1,021,920 -28.62 8,261 6,172 -25.29
2018-02-12 13F-HR SPHERA FUNDS MANAGEMENT LTD. 380,000 479,980 26.31 2,010 2,899 44.23
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,028,163 502,684 -51.11 5,439 3,036 -44.18
2018-02-02 13F-HR GREENWOOD CAPITAL ASSOCIATES LLC 58,968 74,268 25.95 312 449 43.91
2018-02-09 13F-HR SUNTRUST BANKS INC 40,703 40,703 0.00 215 245 13.95
2018-02-09 13F-HR CITADEL ADVISORS LLC Call 25,900 93,000 259.07 137 562 310.22
2017-11-14 13F-HR PARADIGM ASSET MANAGEMENT CO LLC 34,500 0 -100.00 181,815 0 -100.00
2017-11-13 13F-HR Ferris Capital, Llc 2,001 0 -100.00 11 0 -100.00
2018-02-14 13F-HR TUDOR INVESTMENT CORP ET AL 282,925 44,931 -84.12 1,497 271 -81.90
2018-02-12 13F-HR Bayesian Capital Management, LP 54,300 328
2018-04-11 13F-HR Capital Impact Advisors, LLC 200,707 262,899 30.99 1,212 1,280 5.61
2018-02-13 13F-HR OMERS ADMINISTRATION Corp 34,900 0 -100.00 185 0 -100.00
2018-01-26 SC 13G/A JP Morgan Chase & Co 13,396,608 19,648,012 46.66
2018-02-14 13F-HR STA Wealth Management, LLC 13,873 13,873 0.00 73 84 15.07
2017-11-14 13F-HR J. Goldman & Co LP Call 260,000 0 -100.00 1,370 0 -100.00
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 104,649 111,592 6.63 554 674 21.66
2018-01-23 SC 13G/A BlackRock Inc. 10,923,000 14,431,862 32.12
2018-02-12 13F-HR CITIGROUP INC Call 7,800 22,700 191.03 41 137 234.15
2018-02-12 13F-HR Quantbot Technologies LP 35,800 0 -100.00 189 0 -100.00
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 24,450 30,450 24.54 129 184 42.64
2018-02-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 0 11,897 0 72
2018-02-08 13F-HR SEI INVESTMENTS CO 0 827 0 5
2018-02-08 13F-HR Cetera Advisors LLC 42,700 48,650 13.93 225 294 30.67
2018-02-15 13F-HR JANE STREET GROUP, LLC Call 0 23,300 0 141
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 231,200 177,500 -23.23 1,223 1,072 -12.35
2018-02-09 SC 13G VANGUARD GROUP INC 11,403,826
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 237,939 237,939 0.00 1,259 1,437 14.14
2018-02-15 13F-HR JANE STREET GROUP, LLC 26,900 87,147 223.97 142 526 270.42
2018-02-22 13F-HR Wagner Wealth Management, Llc 200 1
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 99,800 31,400 -68.54 528 190 -64.02
2018-02-07 13F-HR OPPENHEIMER & CO INC 74,279 76,758 3.34 393 463 17.81
2018-02-12 13F-HR Commonwealth Equity Services, Llc. 17,727 107
2018-02-13 13F-HR Laurion Capital Management LP 660,152 0 -100.00 3,492 0 -100.00
2017-11-07 13F-HR Carl Domino Inc 44,500 36,500 -17.98 235 193 -17.87
2018-02-14 13F-HR STIFEL FINANCIAL CORP 2,039,896 1,839,503 -9.82 10,803 11,114 2.88
2018-04-05 13F-HR Edge Wealth Management LLC 20,800 800 -96.15 125 4 -96.80
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 16,748 35,061 109.34 88,597 211,768 139.02
2018-02-14 13F-HR TEACHERS ADVISORS INC 667,051 302,244 -54.69 3,529 1,826 -48.26
2018-02-09 13F-HR Stratos Wealth Partners, LTD. 8,000 48
2018-02-13 SC 13G/A FMR LLC / Fidelity 29,487,031 23,068,840 -21.77
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 42,400 91,600 116.04 224 553 146.88
2018-04-05 13F-HR RAYMOND JAMES TRUST N.A. 10,000 10,000 0.00 60 49 -18.33
2018-02-15 13F-HR SANDERS MORRIS HARRIS INC. 543,788 521,500 -4.10 2,877 3,150 9.49
2018-01-24 13F-HR SG Americas Securities, LLC 105,069 104,028 -0.99 556 628 12.95
2018-04-17 13F-HR FOX RUN MANAGEMENT, L.L.C. 11,425 0 -100.00 69 0 -100.00
2018-02-23 13F-HR/A-2 TEACHER RETIREMENT SYSTEM OF TEXAS 13,426 58,000 332.00 71 350 392.96
2018-02-14 13F-HR Squarepoint Ops LLC 22,700 0 -100.00 120 0 -100.00
2018-02-14 13F-HR A.R.T. Advisors, LLC 0 122,808 0 741
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 254,240 254,240 0.00 1,345 1,536 14.20
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 1,342,359 1,606,780 19.70 7,101 9,704 36.66

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( TXMD / TherapeuticsMD, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

TXMD: TherapeuticsMD Analysis and Research Report

2018-02-26 - Asif

TherapeuticsMD was incorporated in Utah in 1907 under the name Croff Mining Company, or Croff. Prior to 2008, Croff’s operations consisted entirely of oil and natural gas leases. Due to a spin-off of its operations in December 2007, Croff had no business operations or revenue source and had reduced its operations to a minimal level although it continued to file reports required under the Securities Exchange Act of 1934, or the Exchange Act. As a result of the spin-off, Croff was a “shell company” under the rules of the Securities and Exchange Commission, or the SEC. In July 2009, Croff (i) closed a transaction to acquire America’s Minority Health Network, Inc. as a wholly owned subsidiary, (ii) ceased being a shell company, and (iii) experienced a change in control in which the former stockholders of America’s Minority Health Network, Inc. acquired control of its company. On June 11, 2010, the company closed a transaction to acquire Spectrum Health Network, Inc. as a wholly owned subsi...

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 88338N107